Werewolf Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
RA CAPITAL MANAGEMENT, L.P. director
 Common Stock 1,853,000 $2.21 $4,095,130
Option
SEIDEL-DUGAN CYNTHIA officer: Chief Scientific Officer
 Stock Option (right to buy) 15,532 $4.77 $74,088
Option
SEIDEL-DUGAN CYNTHIA officer: Chief Scientific Officer
 Stock Option (right to buy) 24,199 $1.56 $37,750
Option
SEIDEL-DUGAN CYNTHIA officer: Chief Scientific Officer
 Common Stock 15,532 $4.77 $74,088
Option
SEIDEL-DUGAN CYNTHIA officer: Chief Scientific Officer
 Common Stock 24,199 $1.56 $37,750
Option
LEONARD REID officer: Chief Operating Officer
 Stock Option (Right to Buy) 14,102 $1.56 $21,999
Option
LEONARD REID officer: Chief Operating Officer
 Common Stock 14,102 $1.56 $21,999
Sale
LEONARD REID officer: Chief Operating Officer
 Common Stock 135 $13.97 $1,886
Sale
LEONARD REID officer: Chief Operating Officer
 Common Stock 2,865 $13.39 $38,357
Purchase
RA CAPITAL MANAGEMENT, L.P.
Common Stock 9,285 $13.37 $124,140
Purchase
RA CAPITAL MANAGEMENT, L.P.
Common Stock 7,958 $12.95 $103,056
Purchase
RA CAPITAL MANAGEMENT, L.P.
Common Stock 306,055 $12.75 $3,902,201
Purchase
LONGWOOD FUND III GP, LLC
Common Stock 250,000 $16 $4,000,000
Purchase
ASANUMA SAKAE
Common Stock 312,500 N/A N/A
Purchase
TAIHO VENTURES LLC
Common Stock 312,500 N/A N/A
Purchase
ARKIN BIO VENTURES 2 L.P.
Common Stock 400,000 N/A N/A
Purchase
RA CAPITAL MANAGEMENT, L.P.
Common Stock 1,715,000 $16 $27,440,000
Purchase
EVNIN LUKE
Common Stock 150,799 N/A N/A
Purchase
GADICKE ANSBERT
Common Stock 245,000 N/A N/A
Purchase
MPM BIOVENTURES 2014, L.P.
Common Stock 125,759 $16 $2,012,144
Purchase
LAZARUS ALON
Common Stock 400,000 $16 $6,400,000
Purchase
SPHERA GLOBAL HEALTHCARE MANAGEMENT LP
Common Stock 475,000 N/A N/A
Purchase
FLYNN JAMES E
Common Stock 800,000 $16 $12,800,000
Purchase
RA CAPITAL MANAGEMENT, L.P.
Common Stock 1,715,000 $16 $27,440,000
Purchase
ASANUMA SAKAE
Series B Preferred Stock 3,797,921 N/A N/A
Purchase
EVNIN LUKE
Series B Preferred Stock 7,939,970 N/A N/A
Purchase
LAZARUS ALON
Series B Preferred Stock 3,560,551 $16 $56,968,816

Showing 1 to 27 of 27 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: